AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220: Peethaambaran ...
Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer: New York Friday, December 12, ...
APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [I ...
China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [IST] T ...
DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance: Shardul Nautiyal, Mumbai Friday, December 12, 2025, 08:00 Hrs [IST] The Directorate Gen ...
NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease: Tokyo Thursday, December 11, 2025, 16:00 Hrs [IST] Toky ...
Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025: Our Bureau, Bengaluru Thursday, December 11, 2025, 17:30 Hrs [IST] Senores Pharmaceuticals is i ...
Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...
Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
Oral semaglutide for weight loss could be a game-changer for obesity care in India: Our Bureau, Mumbai Thursday, December 11, 2025, 15:30 Hrs [IST] New findings presented at Obesi ...